Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience

por Xu, Shuping, Ramos-Suzarte, Mayra, Bai, Xianhong, Xu, Binghe
Publicado 2016

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease

por de Castro-Suárez, Niurys, Trame, Mirjam N., Ramos-Suzarte, Mayra, Dávalos, José M., Bacallao-Mendez, Raymed A., Maceo-Sinabele, Anaelys R., Mangas-Sanjuán, Víctor, Reynaldo-Fernández, Gledys, Rodríguez-Vera, Leyanis
Publicado 2020

Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin

por González Fernández, Sandra, Amador García, Yohan, Boris Porras, Lucien Gregoria, Mojena Martínez, Liuba, Soler Porro, Luis Laureano, Pish Martí, Gustavo, Fonseca Chon, Liem, Estrada Guerra, Yelec, Álvarez Blanco, Jorge Manuel, Garabito Perdomo, Acralys, Santel Odio, Félix Bárbaro, Varona Vázquez, Luis Alfonso, Ricardo Serrano, Yoel Mario, Chao González, Lisette, Avila Albuerne, Yisel, Sánchez Valdés, Lizet, Viada González, Carmen Elena, Ramos Suzarte, Mayra, Saumell Nápoles, Yaimarelis
Publicado 2022